thrombectomy - search results
If you're not happy with the results, please do another search
Computer-assisted vacuum thrombectomy system for patients with pulmonary embolism demonstrates ‘rapid, statistically significant’ improvement...
Patients undergoing computer-assisted vacuum thrombectomy with the Indigo Aspiration System (Penumbra) for pulmonary embolism (PE) showed 2.7% rates of both major adverse events (MAEs)...
Akura thrombectomy system for PE appears safe and demonstrates reduction of RV/LV ratio in...
Results from a first-in-human, prospective, single-arm study of the Akura Medical thrombectomy system (Akura Medical) for pulmonary embolism (PE) were revealed this week at...
REAL-PE demonstrates statistically significant lower major bleeding rates with Ekos system compared to mechanical...
Data from the REAL-PE study were presented this week at TCT 2023 (23–26 October, San Francisco, USA) demonstrating that patients treated for pulmonary embolism...
Behind the procedure: Removing in-stent thrombosis with the RevCore Thrombectomy Catheter
This advertorial is sponsored by Inari Medical.
For patients with in-stent thrombosis (IST), one of the most critical unmet needs has been an effective method...
JETi registry provides “remarkable results” for peripheral thrombectomy system
Presenting “remarkable results” from the JETi registry—a prospective, multicenter, observational study which collected real-world data on the safety, performance and clinical benefits of the...
ACC 2023: Large bore mechanical thrombectomy reduces adverse outcomes in high-risk PE patients
Large bore mechanical thrombectomy with the FlowTriever system (Inari Medical) in patients with high-risk pulmonary embolism (PE) was associated with a significantly lower occurrence...
Penumbra launches Lightning Flash mechanical thrombectomy system
Penumbra have announced the Food and Drug Administration (FDA) clearance and launch of its Lightning Flash mechanical thrombectomy system.
“Lightning Flash features Penumbra’s novel Lightning intelligent...
Mechanical thrombectomy for DVT: Randomized data needed to boost growing evidence base
Two datasets presented during the late-breaking clinical trials session at The VEINS (Venous Endovascular Interventional Strategies) 2022 (Oct. 30–31) in Las Vegas—the latest results...
Surmodics announces successful first patient use of Pounce thrombectomy system
Surmodics has announced that J. Michael Bacharach, MD, a vascular interventionalist/cardiologist at North Central Heart, a division of Avera Heart Hospital in Sioux Falls,...
Surmodics builds thrombectomy portfolio with acquisition of Vetex Medical
Surmodics recently announced that it has acquired privately-held Vetex Medical Limited, expanding the company's thrombectomy portfolio with a second Food and Drug Administration (FDA) 510(k)-cleared...
Vetex Medical announces positive one-year outcomes for ReVene thrombectomy catheter
Vetex Medical has announced positive one-year outcomes from a European clinical study of the ReVene thrombectomy catheter. In patients with iliofemoral vein thrombus, the...
QuickClear mechanical thrombectomy system: A powerfully simple and effective solution
This video is sponsored by Philips.
Craig Walker, MD, of Houma, Louisiana; Bryan Fisher, MD, of Nashville, Tennessee; and Andre Biuckians, MD, of Towson, Maryland,...
Study finds racial disparities in acute stroke thrombectomy management
A new study has found several racial disparities after mechanical thrombectomy for stroke with respect to post-procedure management and outcomes. Vineeth Thirunavu of Northwestern...
One-year CLOUT data demonstrate low rate of PTS following treatment with ClotTriever
David Dexter (Sentara Vascular Specialists, Norfolk, USA) shared one-year data from the CLOUT registry this week at The VEINS 2023 (28–30 October, Las Vegas,...
EVS 2023: New data chart underrepresentation of women at the head of national clinical...
The underrepresentation of women vascular surgeons in national clinical trial leadership formed the central theme of data coming out of a new study that...
Financial viability, appropriate use and patient safety in the operation of outpatient facilities
The number of office-based facilities has been increasing steadily over the past several years—and more vascular surgeons may be considering becoming involved in operating...
Learn the who, the when and the what of treating deep vein thrombosis
Between additional available therapies, multiple new devices now on the market and evolving research supporting thrombus removal, Patrick Muck, MD, and Madhavi Meka, MD,...
VAM 2023: Learn at lunchtime
The Society for Vascular Surgery has added four lunchtime learning sessions to the VAM opening day.
Topics are both clinical and non-clinical, ranging from planning...
BASIL-2 and BEST-CLI: A tale of two limb trials
Optimal treatment of patients with chronic limb-threatening ischemia (CLTI) has been an ongoing debate within the vascular community, fueled by growing numbers of patients,...
FLAME, FLASH and ongoing PEERLESS trials collect ‘compelling’ data for FlowTriever device
Speaking on the FLAME, FLASH and PEERLESS trials that each collected data on the FlowTriever (Inari Medical) device for the treatment of pulmonary embolism...
A call to arms: Reuse of mature venous conduits urged
“Recycle that vein!”—that was the appeal from the authors of a new study that trialled the explantation of mature arteriovenous fistulas (AVFs) from patients...
RESCUE trial shows reduction in segmental and main pulmonary artery occlusions
Robert A. Lookstein, MD, who is executive vice chair, Diagnostic, Molecular and Interventional Radiology at the Icahn School of Medicine at Mount Sinai Hospital...
AVF 2023: One-year analysis of CLOUT registry reveals ‘significant and sustained’ long-term clinical improvements
Interim one-year outcomes from the multicenter, prospective, single-arm CLOUT registry investigating use of the ClotTriever thrombectomy system in all-comer patients with deep vein thrombosis...
First patient enrolled in DEFIANCE trial of the ClotTriever system in DVT
Inari Medical announced that the first patient has been enrolled in DEFIANCE, a prospective randomized controlled trial (RCT) comparing the clinical outcomes of patients...
SVS 10-year research goals: Why create research priorities?
As was the case with the 2011 set, researchers hope the updated priorities will serve as a starting point to align research efforts within...
SVS weighs in on 2023 Medicare payment rules for physicians and hospital outpatient services
The Society for Vascular Surgery (SVS) has submitted comment letters in response to the proposed rules issued by the Centers for Medicare and Medicaid...
Aortobifemoral grafting in the endovascular era: An exploration of the open procedure and its...
Aortobifemoral grafting for aortoiliac occlusive disease (AIOD) probably remains “very safe” in the era of endovascular repair, according to the senior author behind a...
Clinical outcomes of the ClotTriever system in DVT set to be evaluated in RCT
Inari Medical has announced planned enrollment of the DEFIANCE randomized controlled trial (RCT), which is designed to compare the clinical outcomes of patients with...
Tying healthcare waste and spending to productivity incentives
A 74-year-old woman was recently hospitalized for a pulmonary embolus from acute deep vein thrombosis (DVT) of the mildly edematous left lower leg. She...
AngioDynamics announces FDA clearance of expanded indications for Auryon atherectomy system
AngioDynamics recently announced receiving Food and Drug Administration (FDA) 510(k) clearance of an expanded indication for the Auryon atherectomy system to include arterial thrombectomy.
The FDA recently...
Vascular Live: Variety of vascular concerns on the slate
Be sure to save time for the Vascular Live theater-in-the-round presentations in the Exhibit Hall at the 2022 Vascular Annual Meeting (VAM) in Boston....
The top 10 most popular Vascular Specialist stories in April 2022
The digital version of the April 2022 issue of Vascular Specialist, the most recent editorial by our medical editor focusing on diversity within the...
AVF 2022: Six-month CLOUT data indicate ClotTriever can effectively remove full spectrum of thrombus
Six-month outcomes from the ongoing CLOUT registry demonstrate the “safety and efficacy” of the ClotTriever thrombectomy system in a real-world deep vein thrombosis (DVT)...
First patient enrolled in PEERLESS study of FlowTriever system
Inari Medical has announced that the first patient has been enrolled in PEERLESS prospective, randomized controlled trial (RCT) comparing the outcomes of patients with...
Learn by doing at February SVS PAD workshop
The Society for Vascular Surgery (SVS) Peripheral Arterial Disease (PAD) Workshop in February will feature four hours of hands-on surgical skills training, on 10...
Benefits of percutaneous fistula creation further bolstered by five-year Ellipsys data
The Ellipsys vascular access system (Avenu Medical/Medtronic) can be used to easily and safely create durable percutaneous arteriovenous fistulas (pAVFs) for haemodialysis—with new, long-term...
Registry data show greater clot chronicity on post-procedure inspection than initially predicted
Nearly half of patients deemed pre-procedurally to be suffering an acute case of deep vein thrombosis (DVT) turned out to have a “much more”...
First pulmonary embolism patient enrolled in FLAME study
Inari Medical has announced the enrollment of the first high-risk pulmonary embolism (PE) patient in the FLAME (FlowTriever for acute massive pulmonary embolism) study....
Vascular surgery COVID-19 registry participants probe state of practice amid winter surge
The question of the COVID-19 pandemic’s effect on vascular practice continues to occupy members of the specialty. Contributors to a global vascular surgery registry...
Straub Medical announces first patient treated in US with Rotarex S atherectomy device
Straub Medical, the US direct-sales subsidiary of Swiss outfit Straub Medical AG, has announced the launch and first intervention performed with the Rotarex S...
The PERT Movement – Vascular surgeons must answer the call
Pulmonary embolism (PE) is the third most common cause of cardiovascular death in the United States and remains the most common preventable cause of...
Schedule-At-A-Glance
Wednesday, June 8
6:00 a.m. – 6:30 p.m.
Registration
7:00 – 10:00 a.m.
Postgraduate Courses
P1: Controversies and Management of Lower Extremity Arterial Occlusive Disease
P2: Complete Management of Venous...
From the editor: New column launches
This month we are introducing a new feature in Vascular Specialist – a column on medicolegal matters. After all there are few issues that...
Keep RUC in mind
In July, the Society for Vascular Surgery sent requests to its members to complete surveys regarding the work involved with creation, revision, and thrombectomy...
